Problems travel with the mother stock
Material taken repeatedly from the same source can carry hidden biological risks into the next production cycle.
Plant tissue culture · Thailand
Clean genetics.
Clean genetics.
Consistent plants.
Built to scale.
ACL Genetics helps commercial growers, nurseries and plant innovators preserve valuable material, establish clean stock and build reliable propagation programmes.
From mother material to multiplication planEvery project begins with the plant, the biological risk and the commercial objective.
Defined intakeKnow what material enters the process.
Aseptic workflowReduce avoidable contamination risk.
Traceable batchesKeep identity connected to each stage.
Commercial planningMatch biology with the required scale.
The business problem
When propagation becomes the bottleneck
Traditional propagation can work well—until disease pressure, mother-stock limits or batch inconsistency begin to constrain growth.
One crop, many starting points
Uneven age, condition and handling of propagation material can create variation before plants enter the production system.
Demand grows faster than supply
High-value selections may be difficult to preserve and multiply in the volume or timing a commercial programme requires.
Core services
A practical route from selected plant to reliable supply
Projects are scoped around the species, starting material, target scale and delivery stage—not a one-size-fits-all package.
↗
Commercial micropropagation
Structured multiplication programmes for selected crops and cultivars.
◎
Clean-stock establishment
Controlled initiation workflows that create a stronger propagation starting point.
◇
Genetic preservation
In-vitro maintenance and backup of elite or commercially important material.
⌁
Protocol development
Feasibility and optimisation work for new species or difficult cultivars.
Tissue Culture Academy
New to tissue culture? Start with the business questions.
Many companies know the term but do not yet know whether the method fits their crop, volume or commercial objective. Our learning centre makes the process easier to evaluate.
- What tissue culture is
- When it adds value
- How the stages work
- Tissue culture vs. cuttings
- Cost drivers
- How to prepare material
A clear project path
From first material to commercial decision
Each stage answers a different question. Scale should follow evidence, not precede it.
Project review
Define the crop, objective, starting material, target volume and intended delivery stage.
Material intake
Receive and identify plant material, record condition and agree on any limitations.
Culture initiation
Establish material under aseptic conditions and evaluate early response.
Feasibility gate
Review contamination, plant response and technical readiness before scale-up.
Multiplication
Build numbers through controlled cycles while maintaining identity and batch records.
Delivery planning
Coordinate rooting, in-vitro transfer or acclimatisation according to the agreed scope.
Inside ACL
Real plants. Real processes. Real laboratory work.
These images come directly from ACL’s tissue culture activities in Thailand.
Quality & traceabilityHow ACL approaches quality
A controlled process—not a black box
Clients should understand what enters the laboratory, what happens at each stage and what exactly will be delivered.
Material identity
Source and cultivar information recorded at intake.
Stage visibility
Clear project gates from initiation through delivery planning.
Batch labelling
Culture identity connected to project and stage records.
Risk communication
Biological and scaling risks discussed before commitments.
Start with a useful brief
Tell us what you need to preserve, clean up or multiply.
Share the crop, starting material and target scale. We will use it to identify the most sensible next step.